Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Declaration of interest regarding PhD project within the field of biomarker and therapeutic targe...
liver transplantation. The disease is characterized by progressive inflammation and liver fibrosis, yet the mechanisms driving fibrogenesis remain incompletely understood and reliable prognostic
-
causes liver fibrosis/cancer by gain-of-toxic function and chronic obstructive lung disease by loss-of-function. One of our major areas of focus is discovery and testing of autophagy enhancer drugs
-
MED-CORE-PULM Part Time 88134BR Job Summary The UCSF Airway Clinical Research Center (ACRC) integrates research programs in asthma, COPD, sarcoidosis, and cystic fibrosis, along with current
-
program, pulmonary hypertension program, cystic fibrosis program, and research efforts. Faculty benefit from a competitive academic base salary paired with excellent university benefits, including an 8
-
vascular remodeling shapes liver fibrosis progression, regression, and regeneration. The project focuses on the cellular and molecular mechanisms that drive sinusoidal endothelial cell (LSEC) plasticity
-
the American Association of Blood Banks, Clinical Laboratory Improvement Amendments, College of American Pathologists, Cystic Fibrosis Foundation and The Joint Commission. Why Join Our Team? • Innovation: Be
-
Sleep Medicine (Cystic Fibrosis) Position Details Position Description The University of Washington (UW) is recruiting for a full-time Assistant Professor (without tenure due to funding) in the Division
-
Division of Pulmonary Medicine and Cystic Fibrosis Center. The division has a comprehensive Cystic Fibrosis Center (pediatric and adult), a comprehensive sleep disorders program, technology dependent center
-
care medicine. We invite physicians with interest or expertise in cystic fibrosis or pulmonary hypertension to apply. Passion for teaching and mentorship. Contact Dr. Ruxana Sadikot, Chief, Division
-
of lung research, including the pathogenesis, progression and outcomes of asthma, COPD, cystic fibrosis, acute lung injury, pulmonary vascular disease, sleep disordered breathing, and pulmonary fibrosis